|Bid||0.00 x 1800|
|Ask||0.00 x 3000|
|Day's Range||16.85 - 17.49|
|52 Week Range||15.01 - 20.20|
|Beta (5Y Monthly)||0.94|
|PE Ratio (TTM)||22.03|
|Forward Dividend & Yield||1.11 (5.92%)|
|Ex-Dividend Date||Apr 29, 2022|
|1y Target Est||N/A|
HOUSTON, June 29, 2022--Permian Highway Pipeline, LLC announced a final investment decision (FID) to proceed with its expansion project.
HOUSTON, May 16, 2022--Gulf Coast Express Pipeline LLC (GCX) today announced an open season to solicit commitments for an expansion project on its system.
BOSTON, April 26, 2022--Gamida Cell Ltd. (Nasdaq: GMDA), the leader in the development of NAM-enabled cell therapies for patients with solid and hematological cancers and other serious diseases, today announced that updated infection data on omidubicel in comparison to umbilical cord blood transplantation (UCB), was shared in an oral presentation at the 2022 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Tandem Meetings (TCT), being held in Salt Lake City, UT, April 23-26, 2022.